Morgan Stanley’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,680
| Closed | -$1K | – | 6966 |
|
|
2019
Q3 | $1K | Buy |
2,680
+1,763
| +192% | +$658 | ﹤0.01% | 6610 |
|
|
2019
Q2 | $0 | Sell |
917
-627
| -41% | – | ﹤0.01% | 6869 |
|
|
2019
Q1 | $2K | Sell |
1,544
-1,295
| -46% | -$1.68K | ﹤0.01% | 6492 |
|
|
2018
Q4 | $3K | Sell |
2,839
-1,627,631
| -100% | -$1.72M | ﹤0.01% | 6394 |
|
|
2018
Q3 | $4.83M | Buy |
1,630,470
+17,260
| +1% | +$51.1K | ﹤0.01% | 3216 |
|
|
2018
Q2 | $5.94M | Buy |
1,613,210
+3,032
| +0.2% | +$11.2K | ﹤0.01% | 2953 |
|
|
2018
Q1 | $5.64M | Buy |
1,610,178
+418,200
| +35% | +$1.46M | ﹤0.01% | 2898 |
|
|
2017
Q4 | $3.72M | Buy |
1,191,978
+70,470
| +6% | +$220K | ﹤0.01% | 3417 |
|
|
2017
Q3 | $7.88M | Buy |
1,121,508
+603,391
| +116% | +$4.24M | ﹤0.01% | 2518 |
|
|
2017
Q2 | $4.78M | Buy |
518,117
+461,831
| +821% | +$4.26M | ﹤0.01% | 2889 |
|
|
2017
Q1 | $604K | Buy |
56,286
+54,743
| +3,548% | +$587K | ﹤0.01% | 4722 |
|
|
2016
Q4 | $13K | Buy |
+1,543
| New | +$13K | ﹤0.01% | 6108 |
|